{"id":34130,"date":"2024-05-15T15:59:11","date_gmt":"2024-05-15T13:59:11","guid":{"rendered":"https:\/\/www.resist-cluster.de\/?page_id=34130"},"modified":"2024-06-11T01:12:00","modified_gmt":"2024-06-10T23:12:00","slug":"prof-dr-yannic-bartsch","status":"publish","type":"page","link":"https:\/\/www.resist-cluster.de\/en\/about-us\/research-team-2\/prof-dr-yannic-bartsch\/","title":{"rendered":"Prof. Dr. Yannic Bartsch"},"content":{"rendered":"

<\/div>
<\/div>
<\/div>
<\/div>
<\/div>
<\/div>
<\/div><\/div><\/div>
<\/a><\/span><\/div>

Prof. Dr. Yannic Bartsch<\/p>\n<\/div>

<\/div><\/div><\/div>

\n\n\n
<\/i><\/td>\nMy Research Interest in RESIST<\/td>\n<\/tr>\n<\/tbody>\n<\/table><\/h1><\/div>

Antibodies are key components of the adaptive immune system and are critical for defense against infectious diseases. While antibodies can directly block and prevent pathogens from infecting the host through a process called neutralization, recruitment of additional innate effector mechanisms such as phagocytosis or cytotoxicity is often required for effective protection. Within RESIST, we aim to define antibody properties and effector functions that track with protection or susceptibility to infectious diseases. A better understanding of antibody-mediated immunity may lead to the development of better vaccines or antibody-based therapies.<\/p>\n<\/div>

<\/div>
<\/div>
<\/div>
<\/div><\/div><\/div><\/div><\/div>
<\/path><\/svg><\/div>
<\/div><\/div><\/div>
<\/div><\/div><\/div><\/div><\/div>
<\/div>
<\/div>
<\/div>
<\/div>
<\/div><\/div><\/div>
<\/div><\/div><\/div>

Prof. Bartsch<\/h1><\/div>
<\/span><\/div>
<\/div><\/div><\/div><\/div>
<\/div><\/div><\/div>
<\/div><\/div><\/div>
<\/div>
<\/div>
<\/div>
<\/div><\/div><\/div><\/div><\/div><\/div>
<\/path><\/svg><\/div>
<\/div><\/div><\/div>
<\/div><\/div><\/div><\/div><\/div>

Prof. Dr. Yannic Bartsch<\/h1><\/div>
<\/div><\/div><\/div>

Current Position<\/h3><\/div>